Long-Term Follow-Up of an Intensified Myeloablative Conditioning Regimen with In Vivo T Cell Depletion Followed by Allografting in Patients with Advanced Multiple Myeloma-Reference-Cited by-同舟云学术

Long-Term Follow-Up of an Intensified Myeloablative Conditioning Regimen with In Vivo T Cell Depletion Followed by Allografting in Patients with Advanced Multiple Myeloma

Published:2010-06 Issue:6 Volume:16 Page:861-864
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Kröger Nicolaus,Einsele Hermann,Derigs Günter,Wandt Hannes,Krüll Andreas,Zander Axel

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference14 articles.

1. Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells;Corradini;J Clin Oncol,1999

2. Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome;Bensinger;Blood,1996

3. Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning - evidence for a superior outcome using melphalan combined with total body irradiation

4. Reduced-intensity conditioning for myeloma: lower non-relapse mortality but higher relapse rates compared to myeloablative conditioning;Crawley;Blood,2007

5. Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-3 and 1994-98 at European Group for Blood and Marrow Transplantation centres;Gahrton;Br J Haematol,2001

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma;Oncology and Therapy;2022-04-04

2. LDH and renal function are prognostic factors for long-term outcomes of multiple myeloma patients undergoing allogeneic hematopoietic stem cell transplantation;Bone Marrow Transplantation;2020-02-17

3. Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017;Cancer Cell International;2018-04-23

4. Reduced-intensity conditioning allogeneic transplantation after salvage treatment with DT-PACE in myeloma patients relapsing early after autologous transplant;European Journal of Haematology;2017-07-20

5. A transplant “immunome” screening platform defines a targetable epitope fingerprint of multiple myeloma;Blood;2016-06-23